|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant products: stent: 2.5x23 mm xience alpine, 3.0x12 mm xience alpine.The device was not returned for evaluation.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, could not be determined; however, the reported treatments appear to be related to circumstances of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
|
It was reported on (b)(6) 2016 a 2.5x8 mm xience alpine stent, a 2.5x23 mm xience alpine stent and a 3.0x12 mm xience alpine stent were implanted in an unspecified coronary artery.On (b)(6) 2016, the patient was re-admitted for other cardiovascular symptoms, gastrointestinal bleed, unspecified treatment was performed.The final patient outcome was reported as unknown; however, the patient was discharged to home.No additional information was provided.
|